Schedule 13G ownership disclosure

N/A

Security class unavailable · CUSIP: 78667J108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,690,782
Percent of class
9.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-017946
Form type
SC 13G/A
Filer
Sage Therapeutics, Inc.
CIK
CIK 1597553
Filed
Feb 12, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub